Prostate News Archive
27-Dec-2008
Ferring wins FDA approval for prostate cancer drug (Pharmaceutical Business Review)
Ferring Pharmaceuticals USA has received approval from the FDA for degarelix, a new injectable gonadotropin-releasing hormone receptor antagonist, indicated for patients with advanced prostate cancer. Gay/bisexual black men lag behind others in prostate cancer screening (Gayapolis)
Many doctors recommend that once men reach 50, they should be screened for prostate and colorectal cancer. However, not all men get those tests, and a recent study has found that discrepancies exist among some groups. Another prostate cancer obstacle set aside (The North Bay Nugget)
Another obstacle is out of the way for men at risk of developing prostate cancer. The Ontario government recently announced it will cover the cost [...]
Back to Prostate News Archive